Bailard Inc. Makes New Investment in Varex Imaging $VREX

Bailard Inc. purchased a new stake in Varex Imaging (NASDAQ:VREX) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 38,600 shares of the company’s stock, valued at approximately $479,000.

A number of other institutional investors and hedge funds also recently modified their holdings of VREX. Empowered Funds LLC grew its holdings in shares of Varex Imaging by 7.3% in the 1st quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock worth $2,078,000 after acquiring an additional 12,151 shares during the last quarter. Jane Street Group LLC boosted its position in shares of Varex Imaging by 17.9% in the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock valued at $1,849,000 after purchasing an additional 24,160 shares during the period. Voya Investment Management LLC increased its stake in Varex Imaging by 41.2% in the 1st quarter. Voya Investment Management LLC now owns 48,743 shares of the company’s stock worth $565,000 after purchasing an additional 14,217 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Varex Imaging by 25.5% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 13,104 shares of the company’s stock worth $115,000 after buying an additional 2,659 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its holdings in Varex Imaging by 0.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,788,092 shares of the company’s stock worth $23,894,000 after buying an additional 8,680 shares during the period.

Varex Imaging Stock Performance

Shares of VREX opened at $13.85 on Friday. The company has a market capitalization of $580.59 million, a PE ratio of -8.15 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.83 and a current ratio of 3.43. The company’s 50 day moving average price is $12.17 and its 200 day moving average price is $11.18. Varex Imaging has a 52 week low of $6.76 and a 52 week high of $15.46.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.19. The company had revenue of $228.90 million during the quarter, compared to the consensus estimate of $219.26 million. Varex Imaging had a negative net margin of 8.32% and a positive return on equity of 7.19%. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. Research analysts expect that Varex Imaging will post 0.53 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on VREX shares. Oppenheimer decreased their target price on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday, November 19th. B. Riley reaffirmed a “buy” rating and issued a $16.00 price objective on shares of Varex Imaging in a research note on Wednesday, November 19th. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research note on Monday, December 29th. Finally, Wall Street Zen upgraded Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 22nd. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Varex Imaging has a consensus rating of “Hold” and a consensus target price of $17.00.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.